Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis.

Next Previous
Trial Profile

Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Apr 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Efavirenz (Primary) ; Lamivudine; Stavudine; Zidovudine
  • Indications HIV infections
  • Focus Biomarker; Therapeutic Use
  • Acronyms COAT

    • Most Recent Events

    • 11 Mar 2020 Results (n=738), pooled analysis of the data from 3 sequential trials presented at the 27th Conference on Retroviruses and Opportunistic Infections
    • 06 Mar 2013 Primary endpoint results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
    • 06 Mar 2013 This study was halted early by the Data and Safety Monitoring Board due to a substantial excess 6-month mortality in the early ART group.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top